On May 6, 2024, Caplin Point Laboratories Limited informed the stock exchanges that Colombia’s INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA) approved the company’s Softgel Capsules division at Puducherry, Tamil Nadu. Caplin Point Laboratories stated that on May 3, 2024, the site inspection of Unit-1 was done and found compliant with …